Neurofibroma historical perspective: Difference between revisions
Jump to navigation
Jump to search
Sara Mohsin (talk | contribs) |
No edit summary |
||
Line 6: | Line 6: | ||
==Classification== | ==Classification== | ||
*In 18th century, NF1-like cutaneous tumor syndromes appeared in the literature<ref name="pmid10190829">{{cite journal| author=Morse RP| title=Neurofibromatosis type 1. | journal=Arch Neurol | year= 1999 | volume= 56 | issue= 3 | pages= 364-5 | pmid=10190829 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10190829 }} </ref> | *In 18th century, NF1-like [[cutaneous]] tumor syndromes appeared in the literature<ref name="pmid10190829">{{cite journal| author=Morse RP| title=Neurofibromatosis type 1. | journal=Arch Neurol | year= 1999 | volume= 56 | issue= 3 | pages= 364-5 | pmid=10190829 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10190829 }} </ref> | ||
*In 1880s, Friedrich von Recklinghausen published seminal observations detailing cutaneous tumors comprised of both neuronal and fibroblastic tissue finally termed as neurofibroms | *In 1880s, Friedrich von Recklinghausen published seminal observations detailing cutaneous tumors comprised of both [[Neuron|neuronal]] and [[Fibroblast|fibroblastic tissue]] finally termed as neurofibroms. | ||
*In 2006, Yang et al demonstrated a critical neurofibroma microenvironment interaction that includes SCF-stimulated Nf1+/− mast cells potentiating Nf1+/− fibroblast functions.<ref>http://www.bloodjournal.org/content/116/2/157?sso-checked=true</ref> | *In 2006, Yang et al demonstrated a critical neurofibroma microenvironment interaction that includes SCF-stimulated Nf1+/− mast cells potentiating Nf1+/− fibroblast functions.<ref>http://www.bloodjournal.org/content/116/2/157?sso-checked=true</ref> | ||
Revision as of 23:00, 8 April 2019
Neurofibroma Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Neurofibroma historical perspective On the Web |
American Roentgen Ray Society Images of Neurofibroma historical perspective |
Risk calculators and risk factors for Neurofibroma historical perspective |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2]
Overview
In 2006, Yang et al demonstrated a critical neurofibroma microenvironment interaction that includes SCF-stimulated Nf1+/− mast cells potentiating Nf1+/− fibroblast functions.
Classification
- In 18th century, NF1-like cutaneous tumor syndromes appeared in the literature[1]
- In 1880s, Friedrich von Recklinghausen published seminal observations detailing cutaneous tumors comprised of both neuronal and fibroblastic tissue finally termed as neurofibroms.
- In 2006, Yang et al demonstrated a critical neurofibroma microenvironment interaction that includes SCF-stimulated Nf1+/− mast cells potentiating Nf1+/− fibroblast functions.[2]
References
- ↑ Morse RP (1999). "Neurofibromatosis type 1". Arch Neurol. 56 (3): 364–5. PMID 10190829.
- ↑ http://www.bloodjournal.org/content/116/2/157?sso-checked=true